Correlation Between QCR Holdings and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both QCR Holdings and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining QCR Holdings and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between QCR Holdings and Edgewise Therapeutics, you can compare the effects of market volatilities on QCR Holdings and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in QCR Holdings with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of QCR Holdings and Edgewise Therapeutics.
Diversification Opportunities for QCR Holdings and Edgewise Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between QCR and Edgewise is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding QCR Holdings and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and QCR Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on QCR Holdings are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of QCR Holdings i.e., QCR Holdings and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between QCR Holdings and Edgewise Therapeutics
Given the investment horizon of 90 days QCR Holdings is expected to generate 0.34 times more return on investment than Edgewise Therapeutics. However, QCR Holdings is 2.91 times less risky than Edgewise Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 8,059 in QCR Holdings on December 28, 2024 and sell it today you would lose (727.00) from holding QCR Holdings or give up 9.02% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
QCR Holdings vs. Edgewise Therapeutics
Performance |
Timeline |
QCR Holdings |
Edgewise Therapeutics |
QCR Holdings and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with QCR Holdings and Edgewise Therapeutics
The main advantage of trading using opposite QCR Holdings and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if QCR Holdings position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.QCR Holdings vs. Community West Bancshares | QCR Holdings vs. First Financial Northwest | QCR Holdings vs. CF Bankshares | QCR Holdings vs. Home Federal Bancorp |
Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |